StonvexLoading…
StonvexStonvexStonvexCore line items from ANGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $292.50M | $303.91M | $338.75M | $316.22M |
Operating Income | $-39.95M | $-192.44M | $-51.18M | $-28.47M |
Net Income | $-33.99M | $-184.35M | $-52.44M | $-26.55M |
EPS (Diluted) | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
Total Assets | $280.14M | $317.67M | $532.64M | $552.75M |
Total Liabilities | $97.17M | $112.08M | $154.34M | $128.26M |
Cash & Equivalents | $55.89M | $76.06M | $44.62M | $28.82M |
Free Cash Flow OCF − CapEx | $-14.59M | $-30.68M | $-3.73M | $-11.49M |
Shares Outstanding | 40.99M | 40.43M | 39.61M | 39.17M |